Samantha Dowse

Samantha is a Managing Partner and Director at GreyRigge Associates with more than 20 years' experience in the biopharmaceutical industry, including roles at GSK, Ipsen Biopharma, Lonza, and Emergent BioSolutions and the UK Vaccine Task Force. She specialises in CMC strategy, method analytical development, method qualification and validation, and the design and management of complex assay programmes for vaccines, biologics and biosimilars. Samantha also leads product stability study design, and shelf-life modelling and analytical strategy for regulatory submissions across Europe, the USA and China. With deep expertise in Quality by Design, statistical analysis, and CMC project management, she provides tailored, high-quality analytical and outsourcing solutions for global development programmes.